APA (7th ed.) Citation

Masaki Hirabatake, Tomoyuki Mizuno, Tomoyuki Mizuno, Hironori Kato, & Tohru Hashida. (2022). Everolimus pharmacokinetics and exposure-response relationship in Japanese patients with advanced breast cancer. Frontiers Media S.A..

Chicago Style (17th ed.) Citation

Masaki Hirabatake, Tomoyuki Mizuno, Tomoyuki Mizuno, Hironori Kato, and Tohru Hashida. Everolimus Pharmacokinetics and Exposure-response Relationship in Japanese Patients with Advanced Breast Cancer. Frontiers Media S.A., 2022.

MLA (9th ed.) Citation

Masaki Hirabatake, et al. Everolimus Pharmacokinetics and Exposure-response Relationship in Japanese Patients with Advanced Breast Cancer. Frontiers Media S.A., 2022.